First Solar double downgraded to Underperform at JMP Securities
JMP Securities analyst Joseph Osha downgraded First Solar two notches, to Underperform from Outperform, as he believes that recent policy developments in China that have...
Author : The Fly
Valeant upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Douglas Tsao upgraded Valeant Pharmaceuticals to Overweight from Equal Weight and raised his price target for the shares to $29 from $20. The...
Allergan in focus after Appaloosa renews call to split CEO, chairman roles
Shares of Allergan (AGN) are higher in afternoon trading after David Tepper's Appaloosa and Senator Investment Group issued a letter renewing their calls for the...
Tapestry slips after designer Kate Spade found dead in NY
Shares of Tapestry (TPR), which owns the Kate Spade label, are under pressure following reports saying the designer Kate Spade was found dead in her...
Cruise line stocks slip as Morgan Stanley voices oversupply concerns
Shares of Carnival (CCL), Norwegian Cruise Line (NCLH) and Royal Caribbean (RCL) are under pressure after Morgan Stanley analyst Jamie Rollo told investors he remains...
On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cision (CISN) initiated with an Outperform at Baird. 2....
On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ulta Beauty (ULTA) downgraded to Neutral from Buy at...
On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Discovery (DISCA) upgraded to Buy from Neutral at MKM...
ACCC charges ANZ, Citigroup, Deutsche Bank with criminal cartel charges
Citigroup Global Markets Australia Pty Limited (C), Deutsche Bank Aktiengesellschaft (DB) and Australia and New Zealand Banking Group Ltd (ANZBY) have been charged with criminal...
On The Fly: After Hours Movers
HIGHER: VAALCO Energy (EGY), up 8.3% after the company regained NYSE compliance... Mylan (MYL), up 5.2% after the FDA approved Mylan's Fulphila... Twitter (TWTR), up...